

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.16489416 |
| 2 | L-phenylalanine metabolic process (GO:0006558) | 6.16489416 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.16137428 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 6.16137428 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 6.01399111 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.16128213 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.11467474 |
| 8 | negative regulation of fibrinolysis (GO:0051918) | 4.99575131 |
| 9 | cysteine metabolic process (GO:0006534) | 4.92490884 |
| 10 | kynurenine metabolic process (GO:0070189) | 4.79921670 |
| 11 | alpha-linolenic acid metabolic process (GO:0036109) | 4.76334289 |
| 12 | bile acid biosynthetic process (GO:0006699) | 4.73979113 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 4.70048405 |
| 14 | definitive hemopoiesis (GO:0060216) | 4.60105611 |
| 15 | high-density lipoprotein particle remodeling (GO:0034375) | 4.59351584 |
| 16 | lysine metabolic process (GO:0006553) | 4.54614470 |
| 17 | lysine catabolic process (GO:0006554) | 4.54614470 |
| 18 | urea cycle (GO:0000050) | 4.49086524 |
| 19 | urea metabolic process (GO:0019627) | 4.49086524 |
| 20 | regulation of fibrinolysis (GO:0051917) | 4.48254421 |
| 21 | glyoxylate metabolic process (GO:0046487) | 4.46794705 |
| 22 | negative regulation of cholesterol transport (GO:0032375) | 4.46433172 |
| 23 | negative regulation of sterol transport (GO:0032372) | 4.46433172 |
| 24 | glutamate metabolic process (GO:0006536) | 4.34545899 |
| 25 | cellular ketone body metabolic process (GO:0046950) | 4.28312805 |
| 26 | regulation of cholesterol homeostasis (GO:2000188) | 4.24981063 |
| 27 | tryptophan catabolic process (GO:0006569) | 4.19084384 |
| 28 | indole-containing compound catabolic process (GO:0042436) | 4.19084384 |
| 29 | indolalkylamine catabolic process (GO:0046218) | 4.19084384 |
| 30 | regulation of protein activation cascade (GO:2000257) | 4.15384251 |
| 31 | protein carboxylation (GO:0018214) | 4.15055643 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.15055643 |
| 33 | glycine metabolic process (GO:0006544) | 4.09209474 |
| 34 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09094191 |
| 35 | bile acid metabolic process (GO:0008206) | 4.00962421 |
| 36 | tryptophan metabolic process (GO:0006568) | 3.99850109 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 3.98693138 |
| 38 | nitrogen cycle metabolic process (GO:0071941) | 3.97960855 |
| 39 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.94989861 |
| 40 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.94616007 |
| 41 | DNA unwinding involved in DNA replication (GO:0006268) | 3.94322485 |
| 42 | cellular modified amino acid catabolic process (GO:0042219) | 3.92196010 |
| 43 | proline biosynthetic process (GO:0006561) | 3.87366872 |
| 44 | reverse cholesterol transport (GO:0043691) | 3.87014381 |
| 45 | regulation of complement activation (GO:0030449) | 3.86192087 |
| 46 | complement activation, alternative pathway (GO:0006957) | 3.84056042 |
| 47 | coenzyme catabolic process (GO:0009109) | 3.81734929 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 3.79545945 |
| 49 | regulation of cholesterol esterification (GO:0010872) | 3.78819044 |
| 50 | aromatic amino acid family metabolic process (GO:0009072) | 3.76451354 |
| 51 | ribosomal small subunit biogenesis (GO:0042274) | 3.72096409 |
| 52 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.71760042 |
| 53 | protein-lipid complex remodeling (GO:0034368) | 3.68149475 |
| 54 | macromolecular complex remodeling (GO:0034367) | 3.68149475 |
| 55 | plasma lipoprotein particle remodeling (GO:0034369) | 3.68149475 |
| 56 | tyrosine metabolic process (GO:0006570) | 3.68015918 |
| 57 | ketone body metabolic process (GO:1902224) | 3.67817421 |
| 58 | regulation of translational fidelity (GO:0006450) | 3.66560006 |
| 59 | 2-oxoglutarate metabolic process (GO:0006103) | 3.64637444 |
| 60 | serine family amino acid metabolic process (GO:0009069) | 3.63622658 |
| 61 | regulation of early endosome to late endosome transport (GO:2000641) | 3.62215406 |
| 62 | acylglycerol homeostasis (GO:0055090) | 3.58420271 |
| 63 | triglyceride homeostasis (GO:0070328) | 3.58420271 |
| 64 | cellular amino acid catabolic process (GO:0009063) | 3.58402562 |
| 65 | homocysteine metabolic process (GO:0050667) | 3.58113367 |
| 66 | serine family amino acid biosynthetic process (GO:0009070) | 3.57320742 |
| 67 | pentose-phosphate shunt (GO:0006098) | 3.56221496 |
| 68 | nuclear pore complex assembly (GO:0051292) | 3.51222929 |
| 69 | imidazole-containing compound metabolic process (GO:0052803) | 3.46412352 |
| 70 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.43565634 |
| 71 | phospholipid efflux (GO:0033700) | 3.42841991 |
| 72 | plasma lipoprotein particle assembly (GO:0034377) | 3.41928833 |
| 73 | one-carbon metabolic process (GO:0006730) | 3.40098969 |
| 74 | dicarboxylic acid catabolic process (GO:0043649) | 3.39720655 |
| 75 | regulation of triglyceride catabolic process (GO:0010896) | 3.38793479 |
| 76 | valine metabolic process (GO:0006573) | 3.38495336 |
| 77 | amino-acid betaine metabolic process (GO:0006577) | 3.35204653 |
| 78 | activation of Rac GTPase activity (GO:0032863) | 3.33572433 |
| 79 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.30635218 |
| 80 | intestinal cholesterol absorption (GO:0030299) | 3.30140576 |
| 81 | ethanol oxidation (GO:0006069) | 3.26268388 |
| 82 | aspartate family amino acid catabolic process (GO:0009068) | 3.24967953 |
| 83 | oxaloacetate metabolic process (GO:0006107) | 3.23850483 |
| 84 | bile acid and bile salt transport (GO:0015721) | 3.22962276 |
| 85 | cholesterol efflux (GO:0033344) | 3.22687151 |
| 86 | drug catabolic process (GO:0042737) | 3.22196985 |
| 87 | pinocytosis (GO:0006907) | 3.22123496 |
| 88 | protein-lipid complex assembly (GO:0065005) | 3.18676423 |
| 89 | cytolysis (GO:0019835) | 3.17609080 |
| 90 | mitotic chromosome condensation (GO:0007076) | 3.17176145 |
| 91 | sterol catabolic process (GO:0016127) | 3.11923855 |
| 92 | cholesterol catabolic process (GO:0006707) | 3.11923855 |
| 93 | Golgi transport vesicle coating (GO:0048200) | 3.11001593 |
| 94 | COPI coating of Golgi vesicle (GO:0048205) | 3.11001593 |
| 95 | plasma lipoprotein particle clearance (GO:0034381) | 3.10216597 |
| 96 | positive regulation of lipid catabolic process (GO:0050996) | 3.10071817 |
| 97 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.09603008 |
| 98 | protein maturation by protein folding (GO:0022417) | 3.09407106 |
| 99 | negative regulation of cell size (GO:0045792) | 3.08839019 |
| 100 | glucose catabolic process (GO:0006007) | 3.08785169 |
| 101 | adherens junction assembly (GO:0034333) | 3.08401626 |
| 102 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.07483072 |
| 103 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.07087358 |
| 104 | benzene-containing compound metabolic process (GO:0042537) | 3.06896087 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.05961674 |
| 106 | positive regulation of receptor recycling (GO:0001921) | 3.05817811 |
| 107 | cell-substrate adherens junction assembly (GO:0007045) | 3.05478539 |
| 108 | focal adhesion assembly (GO:0048041) | 3.05478539 |
| 109 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.04939091 |
| 110 | low-density lipoprotein particle remodeling (GO:0034374) | 3.02698108 |
| 111 | embryonic process involved in female pregnancy (GO:0060136) | 3.02537663 |
| 112 | 4-hydroxyproline metabolic process (GO:0019471) | 3.00840097 |
| 113 | protein retention in ER lumen (GO:0006621) | 2.99959625 |
| 114 | acetyl-CoA metabolic process (GO:0006084) | 2.99940244 |
| 115 | regulation of RNA export from nucleus (GO:0046831) | 2.98587853 |
| 116 | dosage compensation (GO:0007549) | 2.97167556 |
| 117 | hypotonic response (GO:0006971) | 2.96895904 |
| 118 | organic acid catabolic process (GO:0016054) | 2.95595181 |
| 119 | carboxylic acid catabolic process (GO:0046395) | 2.95595181 |
| 120 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.94080287 |
| 121 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.92350697 |
| 122 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.92221395 |
| 123 | viral transcription (GO:0019083) | 2.91547422 |
| 124 | indolalkylamine metabolic process (GO:0006586) | 2.90842233 |
| 125 | tricarboxylic acid metabolic process (GO:0072350) | 2.90519528 |
| 126 | short-chain fatty acid metabolic process (GO:0046459) | 2.90287989 |
| 127 | formation of translation preinitiation complex (GO:0001731) | 2.90120399 |
| 128 | succinate metabolic process (GO:0006105) | 2.89974056 |
| 129 | acute-phase response (GO:0006953) | 2.88165692 |
| 130 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.85636436 |
| 131 | negative regulation of protein activation cascade (GO:2000258) | 2.85121894 |
| 132 | L-serine metabolic process (GO:0006563) | 2.83698872 |
| 133 | dicarboxylic acid metabolic process (GO:0043648) | 2.83167297 |
| 134 | mRNA stabilization (GO:0048255) | 2.83143930 |
| 135 | RNA stabilization (GO:0043489) | 2.83143930 |
| 136 | NADPH regeneration (GO:0006740) | 2.82630334 |
| 137 | cell-substrate junction assembly (GO:0007044) | 2.81784825 |
| 138 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.81703736 |
| 139 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.77530789 |
| 140 | protein-DNA complex disassembly (GO:0032986) | 2.75365074 |
| 141 | nucleosome disassembly (GO:0006337) | 2.75365074 |
| 142 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.74683796 |
| 143 | stress fiber assembly (GO:0043149) | 2.74561508 |
| 144 | regulation of glucocorticoid metabolic process (GO:0031943) | 2.74131513 |
| 145 | protein localization to endosome (GO:0036010) | 2.72879276 |
| 146 | pore complex assembly (GO:0046931) | 2.71069303 |
| 147 | desmosome organization (GO:0002934) | 2.69937083 |
| 148 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.67905933 |
| 149 | translational termination (GO:0006415) | 2.67220552 |
| 150 | proline metabolic process (GO:0006560) | 2.66607825 |
| 151 | positive regulation of nuclease activity (GO:0032075) | 2.65075698 |
| 152 | cellular protein complex localization (GO:0034629) | 2.63256442 |
| 153 | corticosteroid receptor signaling pathway (GO:0031958) | 2.62904609 |
| 154 | nuclear pore organization (GO:0006999) | 2.61600841 |
| 155 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.58722079 |
| 156 | regulation of histone H3-K27 methylation (GO:0061085) | 2.58533132 |
| 157 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.55918100 |
| 158 | histone H2B ubiquitination (GO:0033523) | 2.54930478 |
| 159 | protein export from nucleus (GO:0006611) | 2.54723554 |
| 160 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.54715712 |
| 161 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.54222663 |
| 162 | epithelial cell-cell adhesion (GO:0090136) | 2.50384894 |
| 163 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.49898933 |
| 164 | regulation of response to osmotic stress (GO:0047484) | 2.49839024 |
| 165 | mitotic sister chromatid cohesion (GO:0007064) | 2.49661867 |
| 166 | protein localization to microtubule (GO:0035372) | 2.49591738 |
| 167 | modulation by symbiont of host cellular process (GO:0044068) | 2.49574667 |
| 168 | cellular hyperosmotic response (GO:0071474) | 2.49459235 |
| 169 | maternal placenta development (GO:0001893) | 2.48034592 |
| 170 | modulation by virus of host process (GO:0019054) | 2.47862365 |
| 171 | apoptotic process involved in morphogenesis (GO:0060561) | 2.47162723 |
| 172 | regulation of integrin activation (GO:0033623) | 2.44658117 |
| 173 | megakaryocyte development (GO:0035855) | 2.44530506 |
| 174 | regulation of translational termination (GO:0006449) | 2.43361225 |
| 175 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.42826404 |
| 176 | mitochondrial fusion (GO:0008053) | 2.40297419 |
| 177 | histone H3-K9 demethylation (GO:0033169) | 2.40132546 |
| 178 | translational elongation (GO:0006414) | 2.39991832 |
| 179 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.38718420 |
| 180 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.37849071 |
| 181 | negative regulation of fatty acid transport (GO:2000192) | 2.36430511 |
| 182 | ribosomal small subunit assembly (GO:0000028) | 2.34792440 |
| 183 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.33221561 |
| 184 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.32750124 |
| 185 | regulation of nuclease activity (GO:0032069) | 2.32379874 |
| 186 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.32340625 |
| 187 | establishment of apical/basal cell polarity (GO:0035089) | 2.31864724 |
| 188 | platelet aggregation (GO:0070527) | 2.31840291 |
| 189 | UV protection (GO:0009650) | 2.30955615 |
| 190 | regulation of superoxide anion generation (GO:0032928) | 2.30873386 |
| 191 | viral life cycle (GO:0019058) | 2.30599014 |
| 192 | protein complex disassembly (GO:0043241) | 2.30519649 |
| 193 | G1 DNA damage checkpoint (GO:0044783) | 2.30365051 |
| 194 | barbed-end actin filament capping (GO:0051016) | 2.29626212 |
| 195 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.29079383 |
| 196 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.28453342 |
| 197 | peptidyl-lysine dimethylation (GO:0018027) | 2.27722601 |
| 198 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.26373961 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.08608626 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.29332707 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.55891883 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.65692537 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.25976816 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.07323849 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.59668953 |
| 8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.58436188 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.56098407 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.02095487 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.01244853 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.65739473 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.55668613 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.47184522 |
| 15 | MYC_22102868_ChIP-Seq_BL_Human | 2.38887847 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.33250414 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.31291689 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.17191885 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.06219622 |
| 20 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.00820438 |
| 21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.91449106 |
| 22 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.90143742 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85841414 |
| 24 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.84868547 |
| 25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.82763987 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.82149317 |
| 27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.81705714 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78305445 |
| 29 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.71701250 |
| 30 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.68898339 |
| 31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.68894518 |
| 32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.65683802 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.61076654 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.59817917 |
| 35 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.54056307 |
| 36 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.52598379 |
| 37 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52508832 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.49078724 |
| 39 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.48428542 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46227592 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43608243 |
| 42 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.43417514 |
| 43 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40454662 |
| 44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37409562 |
| 45 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.37314028 |
| 46 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.37282419 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.36850848 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36668282 |
| 49 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.35854701 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.35145718 |
| 51 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32158196 |
| 52 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.31717929 |
| 53 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.31436906 |
| 54 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.31426119 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31095575 |
| 56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30465212 |
| 57 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.30343471 |
| 58 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.28089954 |
| 59 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27849254 |
| 60 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27060529 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.26845329 |
| 62 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.25711149 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.25508357 |
| 64 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.24607808 |
| 65 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.19442630 |
| 66 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17966186 |
| 67 | KDM2B_26808549_Chip-Seq_K562_Human | 1.17023909 |
| 68 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.15938716 |
| 69 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.15288349 |
| 70 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14040765 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.13193020 |
| 72 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.13165515 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13058070 |
| 74 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.11721521 |
| 75 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11388075 |
| 76 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.10904433 |
| 77 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10894327 |
| 78 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.10320643 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10269313 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.09291497 |
| 81 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09129618 |
| 82 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.08893535 |
| 83 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08828347 |
| 84 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.08663565 |
| 85 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.07376712 |
| 86 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.06441544 |
| 87 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06127350 |
| 88 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06020585 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04947725 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.02994396 |
| 91 | GATA1_19941826_ChIP-Seq_K562_Human | 1.02910158 |
| 92 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02783817 |
| 93 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.02704142 |
| 94 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.02624861 |
| 95 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.01546867 |
| 96 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.01366310 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01202223 |
| 98 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.00702501 |
| 99 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.00551975 |
| 100 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00312150 |
| 101 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.00287703 |
| 102 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.00259038 |
| 103 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00219593 |
| 104 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.99982531 |
| 105 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.99833913 |
| 106 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99596582 |
| 107 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.99270740 |
| 108 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96820263 |
| 109 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96757206 |
| 110 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95113728 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94791885 |
| 112 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93949153 |
| 113 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.92645222 |
| 114 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.92328553 |
| 115 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92192015 |
| 116 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90522267 |
| 117 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88526108 |
| 118 | P68_20966046_ChIP-Seq_HELA_Human | 0.87685510 |
| 119 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.85640367 |
| 120 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.85408384 |
| 121 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.85226890 |
| 122 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84413152 |
| 123 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83697563 |
| 124 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.82384788 |
| 125 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81965064 |
| 126 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.81337580 |
| 127 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.80356586 |
| 128 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.79966830 |
| 129 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.79670378 |
| 130 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.78877519 |
| 131 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.78570544 |
| 132 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.78487337 |
| 133 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78459415 |
| 134 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.77523292 |
| 135 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76895706 |
| 136 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.76782330 |
| 137 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.75255500 |
| 138 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.74882322 |
| 139 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.72951348 |
| 140 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.72887896 |
| 141 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.72207269 |
| 142 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.71783724 |
| 143 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.71677068 |
| 144 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.70960331 |
| 145 | MAF_26560356_Chip-Seq_TH1_Human | 0.70881108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.11033827 |
| 2 | MP0005360_urolithiasis | 6.23627289 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.50771097 |
| 4 | MP0005365_abnormal_bile_salt | 5.35719882 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.33187465 |
| 6 | MP0005451_abnormal_body_composition | 3.65482433 |
| 7 | MP0009840_abnormal_foam_cell | 3.13469525 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.13102893 |
| 9 | MP0003252_abnormal_bile_duct | 3.11908326 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.08418863 |
| 11 | MP0005464_abnormal_platelet_physiology | 3.02188727 |
| 12 | MP0005083_abnormal_biliary_tract | 3.02188387 |
| 13 | MP0004185_abnormal_adipocyte_glucose | 2.99991862 |
| 14 | MP0005409_darkened_coat_color | 2.90273505 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.66569522 |
| 16 | MP0003566_abnormal_cell_adhesion | 2.35541664 |
| 17 | MP0004859_abnormal_synaptic_plasticity | 2.30168999 |
| 18 | MP0004808_abnormal_hematopoietic_stem | 2.26474833 |
| 19 | MP0002396_abnormal_hematopoietic_system | 2.24961968 |
| 20 | MP0000678_abnormal_parathyroid_gland | 2.19456230 |
| 21 | MP0003868_abnormal_feces_composition | 2.18823311 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.18042670 |
| 23 | MP0003329_amyloid_beta_deposits | 2.17448566 |
| 24 | MP0005332_abnormal_amino_acid | 2.15341055 |
| 25 | MP0002909_abnormal_adrenal_gland | 2.08233402 |
| 26 | MP0005666_abnormal_adipose_tissue | 2.04979831 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 2.00008229 |
| 28 | MP0004233_abnormal_muscle_weight | 1.98144458 |
| 29 | MP0009379_abnormal_foot_pigmentation | 1.96808947 |
| 30 | MP0003195_calcinosis | 1.95486995 |
| 31 | MP0003111_abnormal_nucleus_morphology | 1.92982054 |
| 32 | MP0002796_impaired_skin_barrier | 1.90751524 |
| 33 | MP0000609_abnormal_liver_physiology | 1.88497075 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.83417155 |
| 35 | MP0002822_catalepsy | 1.83403777 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.81898971 |
| 37 | MP0003453_abnormal_keratinocyte_physiol | 1.76389078 |
| 38 | MP0001730_embryonic_growth_arrest | 1.70302744 |
| 39 | MP0005501_abnormal_skin_physiology | 1.68942671 |
| 40 | MP0010234_abnormal_vibrissa_follicle | 1.62670124 |
| 41 | MP0005375_adipose_tissue_phenotype | 1.61041284 |
| 42 | MP0004957_abnormal_blastocyst_morpholog | 1.60155896 |
| 43 | MP0002138_abnormal_hepatobiliary_system | 1.58666132 |
| 44 | MP0003191_abnormal_cellular_cholesterol | 1.56370465 |
| 45 | MP0005623_abnormal_meninges_morphology | 1.55300614 |
| 46 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.53893208 |
| 47 | MP0000350_abnormal_cell_proliferation | 1.49931371 |
| 48 | MP0002877_abnormal_melanocyte_morpholog | 1.49465522 |
| 49 | MP0005319_abnormal_enzyme/_coenzyme | 1.47814359 |
| 50 | MP0000604_amyloidosis | 1.46886515 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.43241689 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.42931280 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.42931280 |
| 54 | MP0009278_abnormal_bone_marrow | 1.40364189 |
| 55 | MP0002089_abnormal_postnatal_growth/wei | 1.37393100 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.37060533 |
| 57 | MP0002078_abnormal_glucose_homeostasis | 1.36021676 |
| 58 | MP0000733_abnormal_muscle_development | 1.34025786 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.32514099 |
| 60 | MP0003635_abnormal_synaptic_transmissio | 1.31995119 |
| 61 | MP0003077_abnormal_cell_cycle | 1.29671241 |
| 62 | MP0001944_abnormal_pancreas_morphology | 1.29404187 |
| 63 | MP0002080_prenatal_lethality | 1.27896526 |
| 64 | MP0010630_abnormal_cardiac_muscle | 1.27660166 |
| 65 | MP0002086_abnormal_extraembryonic_tissu | 1.27510842 |
| 66 | MP0000681_abnormal_thyroid_gland | 1.23027547 |
| 67 | MP0003172_abnormal_lysosome_physiology | 1.21869118 |
| 68 | MP0009643_abnormal_urine_homeostasis | 1.20423915 |
| 69 | MP0008004_abnormal_stomach_pH | 1.19135756 |
| 70 | MP0005220_abnormal_exocrine_pancreas | 1.18483116 |
| 71 | MP0009780_abnormal_chondrocyte_physiolo | 1.16511232 |
| 72 | MP0003984_embryonic_growth_retardation | 1.16099228 |
| 73 | MP0008260_abnormal_autophagy | 1.14675050 |
| 74 | MP0004019_abnormal_vitamin_homeostasis | 1.14036298 |
| 75 | MP0001672_abnormal_embryogenesis/_devel | 1.12217755 |
| 76 | MP0005380_embryogenesis_phenotype | 1.12217755 |
| 77 | MP0001697_abnormal_embryo_size | 1.09008921 |
| 78 | MP0001851_eye_inflammation | 1.08991089 |
| 79 | MP0000537_abnormal_urethra_morphology | 1.08006945 |
| 80 | MP0003091_abnormal_cell_migration | 1.07902118 |
| 81 | MP0002063_abnormal_learning/memory/cond | 1.06930989 |
| 82 | MP0002088_abnormal_embryonic_growth/wei | 1.06801667 |
| 83 | MP0010094_abnormal_chromosome_stability | 1.05222137 |
| 84 | MP0005621_abnormal_cell_physiology | 1.05097327 |
| 85 | MP0009931_abnormal_skin_appearance | 1.04420296 |
| 86 | MP0000858_altered_metastatic_potential | 1.03530264 |
| 87 | MP0002060_abnormal_skin_morphology | 1.02168097 |
| 88 | MP0000013_abnormal_adipose_tissue | 1.02125059 |
| 89 | MP0000598_abnormal_liver_morphology | 1.01520270 |
| 90 | MP0000313_abnormal_cell_death | 1.01081959 |
| 91 | MP0003303_peritoneal_inflammation | 1.00924560 |
| 92 | MP0002009_preneoplasia | 1.00327749 |
| 93 | MP0008438_abnormal_cutaneous_collagen | 0.99493663 |
| 94 | MP0001915_intracranial_hemorrhage | 0.98769926 |
| 95 | MP0003693_abnormal_embryo_hatching | 0.98570121 |
| 96 | MP0005187_abnormal_penis_morphology | 0.98388156 |
| 97 | MP0001764_abnormal_homeostasis | 0.98212932 |
| 98 | MP0001216_abnormal_epidermal_layer | 0.97630735 |
| 99 | MP0004947_skin_inflammation | 0.96509515 |
| 100 | MP0008007_abnormal_cellular_replicative | 0.96181307 |
| 101 | MP0005023_abnormal_wound_healing | 0.95371903 |
| 102 | MP0004087_abnormal_muscle_fiber | 0.95337952 |
| 103 | MP0003283_abnormal_digestive_organ | 0.93747188 |
| 104 | MP0002249_abnormal_larynx_morphology | 0.93361454 |
| 105 | MP0010352_gastrointestinal_tract_polyps | 0.92191423 |
| 106 | MP0005636_abnormal_mineral_homeostasis | 0.91812446 |
| 107 | MP0005535_abnormal_body_temperature | 0.91203220 |
| 108 | MP0003763_abnormal_thymus_physiology | 0.90107896 |
| 109 | MP0005257_abnormal_intraocular_pressure | 0.90070283 |
| 110 | MP0000759_abnormal_skeletal_muscle | 0.89111013 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.88682486 |
| 112 | MP0009745_abnormal_behavioral_response | 0.86713048 |
| 113 | MP0004043_abnormal_pH_regulation | 0.86460499 |
| 114 | MP0005384_cellular_phenotype | 0.86048646 |
| 115 | MP0000639_abnormal_adrenal_gland | 0.85990185 |
| 116 | MP0001661_extended_life_span | 0.85553504 |
| 117 | MP0008872_abnormal_physiological_respon | 0.83521295 |
| 118 | MP0003123_paternal_imprinting | 0.82055819 |
| 119 | MP0008932_abnormal_embryonic_tissue | 0.81200145 |
| 120 | MP0000490_abnormal_crypts_of | 0.80171253 |
| 121 | MP0008874_decreased_physiological_sensi | 0.79630185 |
| 122 | MP0004272_abnormal_basement_membrane | 0.79311500 |
| 123 | MP0001346_abnormal_lacrimal_gland | 0.79208809 |
| 124 | MP0001968_abnormal_touch/_nociception | 0.78957713 |
| 125 | MP0001849_ear_inflammation | 0.77142678 |
| 126 | MP0009642_abnormal_blood_homeostasis | 0.76543500 |
| 127 | MP0006138_congestive_heart_failure | 0.76187460 |
| 128 | MP0005084_abnormal_gallbladder_morpholo | 0.76084636 |
| 129 | MP0002019_abnormal_tumor_incidence | 0.76013541 |
| 130 | MP0005448_abnormal_energy_balance | 0.75706448 |
| 131 | MP0003953_abnormal_hormone_level | 0.74095126 |
| 132 | MP0002085_abnormal_embryonic_tissue | 0.72412902 |
| 133 | MP0002925_abnormal_cardiovascular_devel | 0.72308147 |
| 134 | MP0005330_cardiomyopathy | 0.72257613 |
| 135 | MP0009672_abnormal_birth_weight | 0.71179878 |
| 136 | MP0003638_abnormal_response/metabolism_ | 0.70513701 |
| 137 | MP0003315_abnormal_perineum_morphology | 0.70479712 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.69654175 |
| 139 | MP0000703_abnormal_thymus_morphology | 0.68710083 |
| 140 | MP0000467_abnormal_esophagus_morphology | 0.68649056 |
| 141 | MP0002064_seizures | 0.67554437 |
| 142 | MP0004811_abnormal_neuron_physiology | 0.67466910 |
| 143 | MP0005076_abnormal_cell_differentiation | 0.67086914 |
| 144 | MP0006036_abnormal_mitochondrial_physio | 0.66668914 |
| 145 | MP0009333_abnormal_splenocyte_physiolog | 0.66628666 |
| 146 | MP0005165_increased_susceptibility_to | 0.66110649 |
| 147 | MP0005334_abnormal_fat_pad | 0.65646625 |
| 148 | MP0010771_integument_phenotype | 0.63703628 |
| 149 | MP0002928_abnormal_bile_duct | 0.61936643 |
| 150 | MP0001348_abnormal_lacrimal_gland | 0.61809635 |
| 151 | MP0000358_abnormal_cell_content/ | 0.61768264 |
| 152 | MP0004270_analgesia | 0.60935874 |
| 153 | MP0006035_abnormal_mitochondrial_morpho | 0.60891790 |
| 154 | MP0002572_abnormal_emotion/affect_behav | 0.60590522 |
| 155 | MP0005266_abnormal_metabolism | 0.60371807 |
| 156 | MP0001765_abnormal_ion_homeostasis | 0.60244177 |
| 157 | MP0001501_abnormal_sleep_pattern | 0.59771141 |
| 158 | MP0004885_abnormal_endolymph | 0.59525145 |
| 159 | MP0004130_abnormal_muscle_cell | 0.57960672 |
| 160 | MP0008873_increased_physiological_sensi | 0.57075536 |
| 161 | MP0002970_abnormal_white_adipose | 0.55511154 |
| 162 | MP0002269_muscular_atrophy | 0.55466760 |
| 163 | MP0002733_abnormal_thermal_nociception | 0.55446470 |
| 164 | MP0003075_altered_response_to | 0.53675416 |
| 165 | MP0004858_abnormal_nervous_system | 0.53364288 |
| 166 | MP0003633_abnormal_nervous_system | 0.53015274 |
| 167 | MP0005376_homeostasis/metabolism_phenot | 0.52706853 |
| 168 | MP0002069_abnormal_eating/drinking_beha | 0.52684288 |
| 169 | MP0004264_abnormal_extraembryonic_tissu | 0.52189348 |
| 170 | MP0009763_increased_sensitivity_to | 0.50708446 |
| 171 | MP0005647_abnormal_sex_gland | 0.50438698 |
| 172 | MP0003656_abnormal_erythrocyte_physiolo | 0.50351774 |
| 173 | MP0010368_abnormal_lymphatic_system | 0.50096061 |
| 174 | MP0001756_abnormal_urination | 0.49750345 |
| 175 | MP0002234_abnormal_pharynx_morphology | 0.49732851 |
| 176 | MP0005379_endocrine/exocrine_gland_phen | 0.49283370 |
| 177 | MP0000003_abnormal_adipose_tissue | 0.48017116 |
| 178 | MP0005166_decreased_susceptibility_to | 0.46248727 |
| 179 | MP0002971_abnormal_brown_adipose | 0.43055256 |
| 180 | MP0009765_abnormal_xenobiotic_induced | 0.38838267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.22748461 |
| 2 | Deep venous thrombosis (HP:0002625) | 5.97269977 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.43174138 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.19253683 |
| 5 | Xanthomatosis (HP:0000991) | 4.90929949 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.88066867 |
| 7 | Ketosis (HP:0001946) | 4.21139072 |
| 8 | Ketoacidosis (HP:0001993) | 4.13737548 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.05407785 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 3.92007249 |
| 11 | Hypoglycemic seizures (HP:0002173) | 3.83267253 |
| 12 | Hypoglycemic coma (HP:0001325) | 3.80832498 |
| 13 | Hypolipoproteinemia (HP:0010981) | 3.51214763 |
| 14 | Abnormality of the common coagulation pathway (HP:0010990) | 3.44085028 |
| 15 | Hyperammonemia (HP:0001987) | 3.39760910 |
| 16 | Complement deficiency (HP:0004431) | 3.33628484 |
| 17 | Increased mean platelet volume (HP:0011877) | 3.33396131 |
| 18 | Menorrhagia (HP:0000132) | 3.28277288 |
| 19 | Hyperacusis (HP:0010780) | 3.26677344 |
| 20 | Prolonged bleeding time (HP:0003010) | 3.24403416 |
| 21 | Epidermoid cyst (HP:0200040) | 3.19466057 |
| 22 | Distal lower limb amyotrophy (HP:0008944) | 3.18541300 |
| 23 | Abnormal platelet volume (HP:0011876) | 3.15285994 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.10785080 |
| 25 | Abnormality of the lower motor neuron (HP:0002366) | 3.08135668 |
| 26 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.03284850 |
| 27 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.03215635 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.02028864 |
| 29 | Spastic diplegia (HP:0001264) | 2.97918356 |
| 30 | Hyperglycinemia (HP:0002154) | 2.93220056 |
| 31 | Late onset (HP:0003584) | 2.90245353 |
| 32 | Delayed CNS myelination (HP:0002188) | 2.86833765 |
| 33 | Purpura (HP:0000979) | 2.82954732 |
| 34 | Gout (HP:0001997) | 2.82490093 |
| 35 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.79946516 |
| 36 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.79946516 |
| 37 | Fat malabsorption (HP:0002630) | 2.78091798 |
| 38 | Flat acetabular roof (HP:0003180) | 2.76779320 |
| 39 | Hyperthyroidism (HP:0000836) | 2.74733801 |
| 40 | Hypoalphalipoproteinemia (HP:0003233) | 2.70852226 |
| 41 | Ankyloglossia (HP:0010296) | 2.69394566 |
| 42 | Neonatal onset (HP:0003623) | 2.65827400 |
| 43 | Progressive muscle weakness (HP:0003323) | 2.63954770 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.61821297 |
| 45 | Global brain atrophy (HP:0002283) | 2.58807342 |
| 46 | Abnormality of the Achilles tendon (HP:0005109) | 2.56614295 |
| 47 | Abnormality of glycine metabolism (HP:0010895) | 2.56093977 |
| 48 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.56093977 |
| 49 | Symptomatic seizures (HP:0011145) | 2.55939491 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 2.53852549 |
| 51 | Abnormal gallbladder physiology (HP:0012438) | 2.53498741 |
| 52 | Cholecystitis (HP:0001082) | 2.53498741 |
| 53 | Hyperbilirubinemia (HP:0002904) | 2.53486178 |
| 54 | Conjugated hyperbilirubinemia (HP:0002908) | 2.53461378 |
| 55 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.52224004 |
| 56 | Joint hemorrhage (HP:0005261) | 2.48104237 |
| 57 | Cerebral inclusion bodies (HP:0100314) | 2.47632626 |
| 58 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.43014672 |
| 59 | Truncus arteriosus (HP:0001660) | 2.40716814 |
| 60 | Broad face (HP:0000283) | 2.40565862 |
| 61 | Insomnia (HP:0100785) | 2.39985135 |
| 62 | Distal lower limb muscle weakness (HP:0009053) | 2.37289726 |
| 63 | Visual hallucinations (HP:0002367) | 2.36871758 |
| 64 | Hyperparathyroidism (HP:0000843) | 2.36591071 |
| 65 | Abnormality of complement system (HP:0005339) | 2.34743408 |
| 66 | Acanthocytosis (HP:0001927) | 2.34620316 |
| 67 | Hyperglycinuria (HP:0003108) | 2.32886735 |
| 68 | Back pain (HP:0003418) | 2.32622778 |
| 69 | Ulnar bowing (HP:0003031) | 2.32141689 |
| 70 | Asymmetry of the thorax (HP:0001555) | 2.31927263 |
| 71 | Skin nodule (HP:0200036) | 2.30234633 |
| 72 | Abnormal platelet function (HP:0011869) | 2.29300984 |
| 73 | Impaired platelet aggregation (HP:0003540) | 2.29300984 |
| 74 | Hepatocellular carcinoma (HP:0001402) | 2.28293387 |
| 75 | Hypercholesterolemia (HP:0003124) | 2.27656458 |
| 76 | Hyperglycemia (HP:0003074) | 2.27268324 |
| 77 | Petechiae (HP:0000967) | 2.26144165 |
| 78 | Epistaxis (HP:0000421) | 2.25616045 |
| 79 | Status epilepticus (HP:0002133) | 2.24973305 |
| 80 | Protrusio acetabuli (HP:0003179) | 2.23935092 |
| 81 | Abnormality of the tricuspid valve (HP:0001702) | 2.23436539 |
| 82 | Spontaneous abortion (HP:0005268) | 2.23399223 |
| 83 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.21060188 |
| 84 | Dysmetric saccades (HP:0000641) | 2.19619881 |
| 85 | Insidious onset (HP:0003587) | 2.19070065 |
| 86 | Termporal pattern (HP:0011008) | 2.19070065 |
| 87 | Abnormality of the fingertips (HP:0001211) | 2.15479788 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 2.15161914 |
| 89 | Abnormality of the thoracic spine (HP:0100711) | 2.12653570 |
| 90 | Irritability (HP:0000737) | 2.09232286 |
| 91 | Mitral stenosis (HP:0001718) | 2.09074043 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 2.08406999 |
| 93 | Death in childhood (HP:0003819) | 2.08141590 |
| 94 | Cholelithiasis (HP:0001081) | 2.07440267 |
| 95 | Abnormality of oral frenula (HP:0000190) | 2.06109897 |
| 96 | Abnormal social behavior (HP:0012433) | 2.06075815 |
| 97 | Impaired social interactions (HP:0000735) | 2.06075815 |
| 98 | Septate vagina (HP:0001153) | 2.05933807 |
| 99 | Exercise-induced myalgia (HP:0003738) | 2.05026970 |
| 100 | Achilles tendon contracture (HP:0001771) | 2.04844719 |
| 101 | Fragile skin (HP:0001030) | 2.04163211 |
| 102 | Fatigue (HP:0012378) | 2.03774630 |
| 103 | Abnormality of purine metabolism (HP:0004352) | 2.03109662 |
| 104 | Thrombocytosis (HP:0001894) | 2.00922413 |
| 105 | Focal motor seizures (HP:0011153) | 2.00657398 |
| 106 | Abnormality of nucleobase metabolism (HP:0010932) | 1.99646521 |
| 107 | Metabolic acidosis (HP:0001942) | 1.98288773 |
| 108 | Lower limb amyotrophy (HP:0007210) | 1.97194056 |
| 109 | Vertebral compression fractures (HP:0002953) | 1.97010522 |
| 110 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.96504104 |
| 111 | Abnormality of serum amino acid levels (HP:0003112) | 1.96471118 |
| 112 | Testicular neoplasm (HP:0010788) | 1.94673511 |
| 113 | Trismus (HP:0000211) | 1.93358931 |
| 114 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.92720241 |
| 115 | Spinal cord lesions (HP:0100561) | 1.92447341 |
| 116 | Syringomyelia (HP:0003396) | 1.92447341 |
| 117 | Spinal cord compression (HP:0002176) | 1.92405425 |
| 118 | Progressive external ophthalmoplegia (HP:0000590) | 1.91759433 |
| 119 | Short nail (HP:0001799) | 1.91271537 |
| 120 | Elbow flexion contracture (HP:0002987) | 1.91160035 |
| 121 | Bowel incontinence (HP:0002607) | 1.91070196 |
| 122 | Amyotrophic lateral sclerosis (HP:0007354) | 1.90312686 |
| 123 | Hypercortisolism (HP:0001578) | 1.89430109 |
| 124 | Acute hepatic failure (HP:0006554) | 1.88924449 |
| 125 | Tetraplegia (HP:0002445) | 1.87430720 |
| 126 | Hypochromic microcytic anemia (HP:0004840) | 1.87335791 |
| 127 | Abnormality of reticulocytes (HP:0004312) | 1.86434663 |
| 128 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.86128134 |
| 129 | Premature rupture of membranes (HP:0001788) | 1.86052061 |
| 130 | Myocardial infarction (HP:0001658) | 1.85695946 |
| 131 | Cerebral aneurysm (HP:0004944) | 1.85495967 |
| 132 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.85466798 |
| 133 | Myokymia (HP:0002411) | 1.85225689 |
| 134 | Abnormal large intestine physiology (HP:0012700) | 1.84456247 |
| 135 | Self-mutilation (HP:0000742) | 1.84390506 |
| 136 | Seborrheic dermatitis (HP:0001051) | 1.83967774 |
| 137 | Ragged-red muscle fibers (HP:0003200) | 1.82716421 |
| 138 | Deep palmar crease (HP:0006191) | 1.82133154 |
| 139 | Cellulitis (HP:0100658) | 1.81755819 |
| 140 | Reticulocytosis (HP:0001923) | 1.81680302 |
| 141 | Hemorrhage of the eye (HP:0011885) | 1.80510503 |
| 142 | Poor eye contact (HP:0000817) | 1.78541471 |
| 143 | Abnormality of the gallbladder (HP:0005264) | 1.77972136 |
| 144 | Hemiplegia (HP:0002301) | 1.76807046 |
| 145 | Venous abnormality (HP:0002624) | 1.76430995 |
| 146 | Brushfield spots (HP:0001088) | 1.76323571 |
| 147 | Missing ribs (HP:0000921) | 1.76292114 |
| 148 | Neurofibrillary tangles (HP:0002185) | 1.75776722 |
| 149 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.74937673 |
| 150 | Pseudobulbar signs (HP:0002200) | 1.74915702 |
| 151 | Obstructive sleep apnea (HP:0002870) | 1.74880577 |
| 152 | Patellar dislocation (HP:0002999) | 1.74475146 |
| 153 | Abnormality of the calcaneus (HP:0008364) | 1.74062895 |
| 154 | Stroke (HP:0001297) | 1.73677900 |
| 155 | Upper limb amyotrophy (HP:0009129) | 1.73646748 |
| 156 | Distal upper limb amyotrophy (HP:0007149) | 1.73646748 |
| 157 | Deviation of the thumb (HP:0009603) | 1.73413443 |
| 158 | Abnormal cartilage morphology (HP:0002763) | 1.73396934 |
| 159 | Disproportionate tall stature (HP:0001519) | 1.73341091 |
| 160 | 11 pairs of ribs (HP:0000878) | 1.72560158 |
| 161 | Gingival bleeding (HP:0000225) | 1.72512772 |
| 162 | Polycythemia (HP:0001901) | 1.71074140 |
| 163 | Macroorchidism (HP:0000053) | 1.70578266 |
| 164 | Increased connective tissue (HP:0009025) | 1.70057910 |
| 165 | Atelectasis (HP:0100750) | 1.69803615 |
| 166 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.69494505 |
| 167 | Generalized hyperpigmentation (HP:0007440) | 1.69426434 |
| 168 | Heterotopia (HP:0002282) | 1.69268229 |
| 169 | Turricephaly (HP:0000262) | 1.68223965 |
| 170 | Pointed chin (HP:0000307) | 1.67387591 |
| 171 | Growth hormone excess (HP:0000845) | 1.66162566 |
| 172 | Acute lymphatic leukemia (HP:0006721) | 1.66000536 |
| 173 | Abnormal ossification of hand bones (HP:0005921) | 1.65999452 |
| 174 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.64842949 |
| 175 | Thoracic kyphosis (HP:0002942) | 1.64585679 |
| 176 | Abnormality of carpal bone ossification (HP:0006257) | 1.64543128 |
| 177 | Confusion (HP:0001289) | 1.63517684 |
| 178 | Poikilocytosis (HP:0004447) | 1.63367977 |
| 179 | Steatorrhea (HP:0002570) | 1.62972887 |
| 180 | Broad palm (HP:0001169) | 1.62459095 |
| 181 | Craniofacial dystonia (HP:0012179) | 1.61466161 |
| 182 | Unilateral renal agenesis (HP:0000122) | 1.61309300 |
| 183 | Proximal placement of thumb (HP:0009623) | 1.61005354 |
| 184 | Esophageal varix (HP:0002040) | 1.60144512 |
| 185 | Increased variability in muscle fiber diameter (HP:0003557) | 1.56902271 |
| 186 | Mitral regurgitation (HP:0001653) | 1.56403711 |
| 187 | Germ cell neoplasia (HP:0100728) | 1.56031342 |
| 188 | Broad distal phalanx of finger (HP:0009836) | 1.55956614 |
| 189 | Long palpebral fissure (HP:0000637) | 1.55332771 |
| 190 | Polygenic inheritance (HP:0010982) | 1.55183670 |
| 191 | Abnormality of the gastric mucosa (HP:0004295) | 1.54825771 |
| 192 | Difficulty climbing stairs (HP:0003551) | 1.52577018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.96958416 |
| 2 | PKN2 | 3.57306370 |
| 3 | SMG1 | 3.54232628 |
| 4 | PRPF4B | 2.88030259 |
| 5 | MAP3K10 | 2.76577878 |
| 6 | EEF2K | 2.59506160 |
| 7 | IRAK3 | 2.58924283 |
| 8 | FGFR4 | 2.56632756 |
| 9 | BCKDK | 2.53324765 |
| 10 | SCYL2 | 2.49849832 |
| 11 | DAPK2 | 2.41866889 |
| 12 | NME2 | 2.38357892 |
| 13 | NTRK3 | 2.35472267 |
| 14 | KSR1 | 2.34137795 |
| 15 | NTRK1 | 2.30503167 |
| 16 | EPHA4 | 2.26361871 |
| 17 | SIK1 | 2.23417264 |
| 18 | MAP3K9 | 2.16533515 |
| 19 | ERN1 | 2.12932769 |
| 20 | MAP2K4 | 2.01667497 |
| 21 | EPHA2 | 2.01162738 |
| 22 | GRK6 | 2.00205918 |
| 23 | MST1R | 1.96659592 |
| 24 | KSR2 | 1.93936654 |
| 25 | MAP3K2 | 1.72108976 |
| 26 | INSRR | 1.71977932 |
| 27 | TTN | 1.61265096 |
| 28 | RPS6KB2 | 1.58657589 |
| 29 | MINK1 | 1.57027318 |
| 30 | RET | 1.53568734 |
| 31 | MAP3K4 | 1.53163631 |
| 32 | EIF2AK1 | 1.52174333 |
| 33 | SIK2 | 1.51396225 |
| 34 | PTK6 | 1.49828121 |
| 35 | ALK | 1.45904209 |
| 36 | TYRO3 | 1.36492568 |
| 37 | PASK | 1.35003149 |
| 38 | DAPK1 | 1.30394490 |
| 39 | CAMKK1 | 1.24297096 |
| 40 | HIPK2 | 1.23921203 |
| 41 | PBK | 1.11591490 |
| 42 | BRAF | 1.08487595 |
| 43 | SIK3 | 1.06708751 |
| 44 | FLT3 | 1.05459256 |
| 45 | MAP4K1 | 1.01976948 |
| 46 | PRKD3 | 1.01853663 |
| 47 | TAOK1 | 0.99769858 |
| 48 | TAOK2 | 0.94259808 |
| 49 | PAK6 | 0.93962816 |
| 50 | PDGFRA | 0.90213616 |
| 51 | CDK7 | 0.89337769 |
| 52 | PAK3 | 0.88845103 |
| 53 | NTRK2 | 0.88600919 |
| 54 | ILK | 0.86697053 |
| 55 | IRAK2 | 0.86635027 |
| 56 | MAP3K1 | 0.86602224 |
| 57 | TGFBR1 | 0.83861861 |
| 58 | MET | 0.81184375 |
| 59 | MAP3K7 | 0.80496158 |
| 60 | ZAP70 | 0.78235872 |
| 61 | CDK8 | 0.77784146 |
| 62 | RIPK1 | 0.77137841 |
| 63 | LRRK2 | 0.77004354 |
| 64 | MAP3K8 | 0.76434946 |
| 65 | MARK2 | 0.75165935 |
| 66 | UHMK1 | 0.74331394 |
| 67 | PRKCH | 0.73132190 |
| 68 | TNK2 | 0.71090422 |
| 69 | MAPK11 | 0.70907638 |
| 70 | RPS6KL1 | 0.70469820 |
| 71 | RPS6KC1 | 0.70469820 |
| 72 | JAK2 | 0.69469079 |
| 73 | EPHA3 | 0.69020865 |
| 74 | FER | 0.69008065 |
| 75 | CDK5 | 0.68011012 |
| 76 | PAK4 | 0.67969377 |
| 77 | PTK2 | 0.67262323 |
| 78 | PIM2 | 0.67000855 |
| 79 | RPS6KA2 | 0.66017807 |
| 80 | MAP2K2 | 0.64465753 |
| 81 | AKT2 | 0.62908299 |
| 82 | PNCK | 0.62719244 |
| 83 | MAP2K3 | 0.61415375 |
| 84 | MAP3K5 | 0.61098147 |
| 85 | MAP3K3 | 0.59934667 |
| 86 | CDK9 | 0.58941255 |
| 87 | NEK2 | 0.57560811 |
| 88 | PRKCG | 0.57209562 |
| 89 | PRKG2 | 0.56763260 |
| 90 | ICK | 0.56679844 |
| 91 | ARAF | 0.55205128 |
| 92 | MAP3K6 | 0.54106431 |
| 93 | FES | 0.54016836 |
| 94 | MAP3K14 | 0.53907295 |
| 95 | AURKA | 0.53657492 |
| 96 | MTOR | 0.53281444 |
| 97 | CHEK1 | 0.53072168 |
| 98 | CHEK2 | 0.52624382 |
| 99 | CDK6 | 0.49968608 |
| 100 | FGFR2 | 0.47757213 |
| 101 | PDK1 | 0.47744048 |
| 102 | CDK4 | 0.47439312 |
| 103 | MAP3K13 | 0.46734691 |
| 104 | BRD4 | 0.46628600 |
| 105 | MARK1 | 0.46551471 |
| 106 | MAP3K11 | 0.45762687 |
| 107 | RPS6KB1 | 0.45601521 |
| 108 | RIPK4 | 0.45086563 |
| 109 | JAK1 | 0.44396982 |
| 110 | MAP2K1 | 0.44230431 |
| 111 | CSNK1E | 0.44094922 |
| 112 | LATS2 | 0.43528510 |
| 113 | MAPK15 | 0.42169937 |
| 114 | PAK2 | 0.42094340 |
| 115 | STK4 | 0.42059596 |
| 116 | TAOK3 | 0.41363963 |
| 117 | MAPKAPK3 | 0.41037184 |
| 118 | CSNK1G2 | 0.41023033 |
| 119 | RPS6KA6 | 0.40584145 |
| 120 | MELK | 0.40434755 |
| 121 | ERBB4 | 0.40271026 |
| 122 | RAF1 | 0.38886345 |
| 123 | TESK1 | 0.38418402 |
| 124 | MAPK10 | 0.38195715 |
| 125 | TBK1 | 0.38006158 |
| 126 | MAP2K6 | 0.37328382 |
| 127 | PRKCZ | 0.37257239 |
| 128 | STK11 | 0.36398209 |
| 129 | MAPK12 | 0.36003026 |
| 130 | BTK | 0.34905053 |
| 131 | CDK2 | 0.34691457 |
| 132 | CDC42BPA | 0.34094245 |
| 133 | FGFR3 | 0.33327324 |
| 134 | NEK1 | 0.32756131 |
| 135 | PRKACG | 0.32498217 |
| 136 | CDK12 | 0.32314341 |
| 137 | RPS6KA3 | 0.32183026 |
| 138 | RPS6KA1 | 0.31523701 |
| 139 | ERBB2 | 0.30823744 |
| 140 | PAK1 | 0.30164640 |
| 141 | WNK1 | 0.30039121 |
| 142 | SGK3 | 0.29544073 |
| 143 | EPHB1 | 0.29486733 |
| 144 | DAPK3 | 0.28912368 |
| 145 | PDPK1 | 0.28679497 |
| 146 | BMX | 0.28520298 |
| 147 | DMPK | 0.28427926 |
| 148 | ATR | 0.27734439 |
| 149 | CAMK1G | 0.27648356 |
| 150 | LMTK2 | 0.26648950 |
| 151 | STK38 | 0.25687064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.40078170 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.20723527 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.79096092 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.16595564 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.05536403 |
| 6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.68479472 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.51574150 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.33110812 |
| 9 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.30196526 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.21415017 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.17228898 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14100719 |
| 13 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.13964469 |
| 14 | Pancreatic cancer_Homo sapiens_hsa05212 | 2.13446105 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.13361185 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.07777642 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.04800043 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.96442619 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.89488781 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.88142400 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.84930881 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.80842765 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76895411 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72706835 |
| 25 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.72018360 |
| 26 | Endometrial cancer_Homo sapiens_hsa05213 | 1.68806199 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.68050382 |
| 28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.60991719 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.60197334 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.56423171 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.55564716 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.51339821 |
| 33 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.49112391 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.45733643 |
| 35 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.44531985 |
| 36 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.40429118 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.38505259 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36630487 |
| 39 | DNA replication_Homo sapiens_hsa03030 | 1.36382410 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35814027 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.33366467 |
| 42 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.32553969 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.32088277 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31543851 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31464947 |
| 46 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.28612312 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.27274305 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27236787 |
| 49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26889425 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23322899 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21752561 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.17326422 |
| 53 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.16636957 |
| 54 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16265865 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 1.15602887 |
| 56 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15514418 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13669299 |
| 58 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.13134098 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.12496853 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11443257 |
| 61 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.10867673 |
| 62 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.10414084 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10403021 |
| 64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.09750461 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09638310 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.09628103 |
| 67 | Prostate cancer_Homo sapiens_hsa05215 | 1.08656317 |
| 68 | Ribosome_Homo sapiens_hsa03010 | 1.07601469 |
| 69 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.07407452 |
| 70 | Colorectal cancer_Homo sapiens_hsa05210 | 1.05127165 |
| 71 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01053273 |
| 72 | Focal adhesion_Homo sapiens_hsa04510 | 0.99719785 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92341481 |
| 74 | Cell cycle_Homo sapiens_hsa04110 | 0.91999955 |
| 75 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91426461 |
| 76 | Long-term potentiation_Homo sapiens_hsa04720 | 0.91423932 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.90595682 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89942149 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.88810303 |
| 80 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.88289768 |
| 81 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86691164 |
| 82 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.83627167 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83442072 |
| 84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81416593 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.81303451 |
| 86 | Base excision repair_Homo sapiens_hsa03410 | 0.80506180 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80108172 |
| 88 | Lysine degradation_Homo sapiens_hsa00310 | 0.80025558 |
| 89 | Adherens junction_Homo sapiens_hsa04520 | 0.79332411 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.79285825 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.78336541 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.77324492 |
| 93 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.76298031 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.76076147 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.75826506 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.74820791 |
| 97 | Insulin secretion_Homo sapiens_hsa04911 | 0.73193869 |
| 98 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.72857771 |
| 99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.72816587 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.71819606 |
| 101 | Alcoholism_Homo sapiens_hsa05034 | 0.71463096 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.71133360 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.70793125 |
| 104 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70318243 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70049851 |
| 106 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68986217 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68426774 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.68162779 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65074521 |
| 110 | Spliceosome_Homo sapiens_hsa03040 | 0.63631723 |
| 111 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.63039790 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.61270823 |
| 113 | GABAergic synapse_Homo sapiens_hsa04727 | 0.61191270 |
| 114 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.60459981 |
| 115 | Retinol metabolism_Homo sapiens_hsa00830 | 0.59717369 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.59483311 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59323027 |
| 118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59216944 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58991234 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.57207046 |
| 121 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56614970 |
| 122 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56232169 |
| 123 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.56191033 |
| 124 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55304613 |
| 125 | Gap junction_Homo sapiens_hsa04540 | 0.54957897 |
| 126 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.54711657 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53360902 |
| 128 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53144601 |
| 129 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.51981291 |
| 130 | Melanoma_Homo sapiens_hsa05218 | 0.51765958 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51463351 |
| 132 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51459166 |
| 133 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50233887 |
| 134 | RNA transport_Homo sapiens_hsa03013 | 0.50152943 |
| 135 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49410381 |
| 136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.48618763 |
| 137 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.48056615 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.46391934 |
| 139 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43791992 |
| 140 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42726090 |
| 141 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41913653 |
| 142 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.41799206 |
| 143 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41067684 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40693950 |
| 145 | Circadian entrainment_Homo sapiens_hsa04713 | 0.39315950 |
| 146 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35915500 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35820633 |
| 148 | Bladder cancer_Homo sapiens_hsa05219 | 0.35011986 |
| 149 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33538449 |
| 150 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32475572 |
| 151 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32317215 |
| 152 | Glioma_Homo sapiens_hsa05214 | 0.30345367 |
| 153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29888807 |
| 154 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29417616 |
| 155 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27651535 |
| 156 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.25947645 |
| 157 | Salivary secretion_Homo sapiens_hsa04970 | 0.25044415 |
| 158 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.23139045 |
| 159 | Taste transduction_Homo sapiens_hsa04742 | 0.21650369 |
| 160 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21262016 |
| 161 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.20506329 |
| 162 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20458945 |
| 163 | Olfactory transduction_Homo sapiens_hsa04740 | 0.20454851 |
| 164 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.19435448 |
| 165 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.18040204 |
| 166 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.17346450 |

